Wellgistics Health, Inc. Common Stock
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, … Read more
Wellgistics Health, Inc. Common Stock (WGRX) - Total Assets
Latest total assets as of September 2025: $52.78 Million USD
Based on the latest financial reports, Wellgistics Health, Inc. Common Stock (WGRX) holds total assets worth $52.78 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Wellgistics Health, Inc. Common Stock - Total Assets Trend (2022–2024)
This chart illustrates how Wellgistics Health, Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Wellgistics Health, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
Wellgistics Health, Inc. Common Stock's total assets of $52.78 Million consist of 26.5% current assets and 73.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.8% |
| Accounts Receivable | $3.75 Million | 6.5% |
| Inventory | $9.52 Million | 16.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $22.36 Million | 39.0% |
| Goodwill | $16.22 Million | 28.3% |
Asset Composition Trend (2022–2024)
This chart illustrates how Wellgistics Health, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wellgistics Health, Inc. Common Stock's current assets represent 26.5% of total assets in 2024, an increase from 0.0% in 2022.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2024, up from 0.0% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 67.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is intangible assets at 39.0% of total assets.
Wellgistics Health, Inc. Common Stock Competitors by Total Assets
Key competitors of Wellgistics Health, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Wellgistics Health, Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Wellgistics Health, Inc. Common Stock generates 0.32x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Wellgistics Health, Inc. Common Stock is currently not profitable relative to its asset base.
Wellgistics Health, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.39 | 0.44 | 0.12 |
| Quick Ratio | 0.16 | 0.14 | 0.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-19.92 Million | $ -18.51 Million | $ -2.55 Million |
Wellgistics Health, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Wellgistics Health, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.21 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 16844.1% |
| Total Assets | $57.33 Million |
| Market Capitalization | $6.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wellgistics Health, Inc. Common Stock's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Wellgistics Health, Inc. Common Stock's assets grew by 16844.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Wellgistics Health, Inc. Common Stock (2022–2024)
The table below shows the annual total assets of Wellgistics Health, Inc. Common Stock from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $57.33 Million | +16844.08% |
| 2023-12-31 | $338.36K | -- |
| 2022-12-31 | $0.00 | -- |